Pharmaco-metabolomicsMetabolite changes due to the metabolism of pharmaceutical compounds

Displaying entries 3076 - 3084 of 3084 in total

Drug	Drug Groups	Metabolite	Change	Description	Reference
					Clear
Sulfisoxazole	Approved Vet Approved	total bilirubin	decreased	Sulfisoxazole decreases the level of total bilirubin in the blood	A26367
Cilostazol	Approved Investigational	creatinine	decreased	Cilostazol decreases the level of creatinine in the blood	A26368 A26369
Lovastatin	Approved Investigational	VLDL triglycerides	decreased	Lovastatin decreases the level of VLDL triglycerides in the blood	A26370
Lovastatin	Approved Investigational	cholesteryl ester	decreased	Lovastatin decreases the level of cholesteryl ester in the blood	A26371
Aliskiren	Approved Investigational	cardiac bradykinin	increased	Aliskiren increases the level of cardiac bradykinin in the blood	A26372
Leuprolide	Approved Investigational	Androstenedione	decreased	Leuprolide decreases the level of Androstenedione in the blood	A25022
Leuprolide	Approved Investigational	Androstanediol glucuronide	decreased	Leuprolide decreases the level of Androstanediol glucuronide in the blood	A25022
Dexamethasone	Approved Investigational Vet Approved	Testosterone	decreased	Dexamethasone decreases the level of Testosterone in the blood	A25022
Leuprolide	Approved Investigational	Estradiol	decreased	Leuprolide decreases the level of Estradiol in the blood	A26373

Displaying entries 3076 - 3084 of 3084 in total